Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray

NCT03223896 is registered in ClinicalTrials.gov with Finnish Institute for Health and Welfare as lead sponsor.

NCT NCT03223896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03223896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray
Lead sponsor
Finnish Institute for Health and Welfare
Phase
Phase 2
Overall status
Completed
Start date
February 14, 2017
Completion date
June 30, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gambling, naloxone, opioid, spray